TFX

Teleflex Incorporated

$155.30

0.37%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.

Source: Yahoo Finance
AI summary

Price & performance

1M+21.5%
3M+11.5%
YTD+25.3%
1Y+23.3%
52-week range—
Beta0.72
Full chart and returns against a benchmark

Q-Score

55/ 100

Quality against peers; 50 is the peer median.

Growth55
Risk62
Performance38
Valuation70
Profitability60
Leverage51
Sentiment56
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2B+17.2%
Net income-$905.6M-1399.8%
Net margin-45.4%-49.5 pts
Historical fundamentals

Revenue exposure

41%of revenue from outside the US
United States59%
Europe24%
Asia and Asia Pacific11%
Regions, segments, customers and suppliers

Valuation

TFXIndustryP/E20.2249.36P/S2.733.73EV/EBITDA17.4223.12P/B1.763.92PEG——
Dividend yield0.95%
Every valuation metric

Earnings

Nov 5next report, before the open
EPS estimate$1.89
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate